Actively Recruiting
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Led by Veradermics, Inc. · Updated on 2025-11-24
552
Participants Needed
71
Research Sites
127 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will evaluate the safety and efficacy of VDPHL01 in female subjects with Androgenetic Alopecia (AGA). AGA is a genetic disorder caused by an excessive (too much) hair follicle response to androgens (hormones) that causes hair loss. VDPHL01 is an investigational oral drug to treat AGA. This multi-center, double blind, study will last about 13 months and includes 11 study visits (screening, baseline (day 1), week 2, month 1, month 2, month 4, month 6, month 8, month 10, month 12, month 13).
CONDITIONS
Official Title
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female aged 18 to 65 years
- Clinical diagnosis of mild to moderate androgenetic alopecia
- Good general health with adequate kidney and liver function
- Willing to maintain hair length of at least 1/4 inch with consistent hairstyle and color throughout the study
- Willing and able to take the study drug as directed and complete questionnaires in English
- Able to swallow study medication whole
- Agree to have a micro dot tattoo placed on the scalp
- Agree to have the tattooed area photographed during study visits
You will not qualify if you...
- Uncontrolled blood pressure or orthostatic hypotension
- History or symptoms of certain heart or thyroid conditions
- Hair loss due to causes other than androgenetic alopecia
- Recent or current dietary or weight changes, including use of GLP-1 agonists
- Diagnosed with COVID-19 within 16 weeks before baseline
- Previous radiation treatment to the scalp
- Use of hormone replacement therapy or hormonal modulators within 6 months before screening
- Use of oral hair growth treatments or systemic retinoids within 6 months before screening
- Use of systemic calcium channel blockers or beta blockers within 12 weeks before screening
- Use of systemic cimetidine, ketoconazole, diazoxide, or corticosteroids within 12 weeks before screening
- Any scalp procedures (surgical, laser, light or energy treatments, micro-needling, injections, platelet rich plasma) within 6 months before screening
- Use of any topical scalp treatments for hair growth within 12 weeks before screening
- Use of any other medication or therapy that might interfere with the study, as judged by the investigator
- Any other condition that might interfere with study participation, as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 71 locations
1
Site 73
Birmingham, Alabama, United States, 35209
Actively Recruiting
2
Site 89
Birmingham, Alabama, United States, 35244
Actively Recruiting
3
Site 77
Phoenix, Arizona, United States, 85006
Actively Recruiting
4
Site 30
Fort Smith, Arkansas, United States, 72916
Actively Recruiting
5
Site 69
Encino, California, United States, 91436
Actively Recruiting
6
Site 2
Fremont, California, United States, 94538
Actively Recruiting
7
Site 64
Manhattan Beach, California, United States, 90266
Actively Recruiting
8
Site 93
Northridge, California, United States, 91324
Actively Recruiting
9
Site 66
Santa Monica, California, United States, 90404
Actively Recruiting
10
Site 34
Sherman Oaks, California, United States, 91403
Actively Recruiting
11
Site 94
Thousand Oaks, California, United States, 91320
Actively Recruiting
12
Site 21
Vista, California, United States, 92083
Actively Recruiting
13
Site 5
Castle Rock, Colorado, United States, 80109
Actively Recruiting
14
Site 24
Greenwood Village, Colorado, United States, 80111
Actively Recruiting
15
Site 17
Aventura, Florida, United States, 33180
Actively Recruiting
16
Site 71
Boca Raton, Florida, United States, 33486
Actively Recruiting
17
Site 86
Coral Gables, Florida, United States, 33134
Actively Recruiting
18
Site 62
Coral Gables, Florida, United States, 33146
Actively Recruiting
19
Site 99
Miami, Florida, United States, 33173
Actively Recruiting
20
Site 54
Ocala, Florida, United States, 34470
Actively Recruiting
21
Site 43
Atlanta, Georgia, United States, 30329
Actively Recruiting
22
Site 90
Sandy Springs, Georgia, United States, 30328
Actively Recruiting
23
Site 31
Boise, Idaho, United States, 83704
Actively Recruiting
24
Site 61
Chicago, Illinois, United States, 60610
Not Yet Recruiting
25
Site 53
Clarksville, Indiana, United States, 47129
Actively Recruiting
26
Site 15
Indianapolis, Indiana, United States, 46250
Actively Recruiting
27
Site 32
New Albany, Indiana, United States, 47150
Actively Recruiting
28
Site 55
Plainfield, Indiana, United States, 46168
Actively Recruiting
29
Site 27
West Lafayette, Indiana, United States, 47906
Actively Recruiting
30
Site 79
Leawood, Kansas, United States, 66211
Actively Recruiting
31
Site 52
Louisville, Kentucky, United States, 40241
Actively Recruiting
32
Site 41
Baton Rouge, Louisiana, United States, 70809
Actively Recruiting
33
Site 13
Covington, Louisiana, United States, 70433
Actively Recruiting
34
Site 12
Metairie, Louisiana, United States, 70006
Actively Recruiting
35
Site 75
New Orleans, Louisiana, United States, 70124
Actively Recruiting
36
Site 84
Glenn Dale, Maryland, United States, 20769
Actively Recruiting
37
Site 87
Rockville, Maryland, United States, 20850
Actively Recruiting
38
Site 22
Brighton, Massachusetts, United States, 02135
Actively Recruiting
39
Site 80
Chestnut Hill, Massachusetts, United States, 02467
Actively Recruiting
40
Site 59
Quincy, Massachusetts, United States, 02169
Actively Recruiting
41
Site 26
Clarkston, Michigan, United States, 48346
Actively Recruiting
42
Site 68
Clinton Township, Michigan, United States, 48038
Actively Recruiting
43
Site 83
Southfield, Michigan, United States, 48034
Not Yet Recruiting
44
Site 98
Medina, Minnesota, United States, 55340
Not Yet Recruiting
45
Site 56
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
46
Site 6
New Brighton, Minnesota, United States, 55112
Actively Recruiting
47
Site 18
Hackensack, New Jersey, United States, 07601
Actively Recruiting
48
Site 37
Kew Gardens, New York, United States, 11415
Actively Recruiting
49
Site 97
New York, New York, United States, 10003
Not Yet Recruiting
50
Site 82
Hickory, North Carolina, United States, 28602
Actively Recruiting
51
Site 92
Huntersville, North Carolina, United States, 28078
Actively Recruiting
52
Site 39
Boardman, Ohio, United States, 44512
Actively Recruiting
53
Site 72
Cincinnati, Ohio, United States, 45236
Actively Recruiting
54
Site 11
Columbus, Ohio, United States, 43215
Actively Recruiting
55
Site 57
Portland, Oregon, United States, 97210
Actively Recruiting
56
Site 60
Anderson, South Carolina, United States, 29621
Actively Recruiting
57
Site 95
Hermitage, Tennessee, United States, 37076
Actively Recruiting
58
Site 9
Knoxville, Tennessee, United States, 37909
Actively Recruiting
59
Site 4
Nashville, Tennessee, United States, 37215
Actively Recruiting
60
Site 76
Austin, Texas, United States, 78746
Actively Recruiting
61
Site 74
College Station, Texas, United States, 77845
Actively Recruiting
62
Site 67
Dallas, Texas, United States, 75230
Not Yet Recruiting
63
Site 14
Houston, Texas, United States, 77056
Terminated
64
Site 88
San Antonio, Texas, United States, 78218
Actively Recruiting
65
Site 91
Sugar Land, Texas, United States, 77479
Actively Recruiting
66
Site 19
South Jordan, Utah, United States, 84095
Actively Recruiting
67
Site 29
Forest, Virginia, United States, 24551
Actively Recruiting
68
Site 63
Norfolk, Virginia, United States, 23502
Actively Recruiting
69
Site 85
Norfolk, Virginia, United States, 23502
Actively Recruiting
70
Site 33
Burien, Washington, United States, 98168
Actively Recruiting
71
Site 70
Mill Creek, Washington, United States, 98012
Actively Recruiting
Research Team
A
AGA Study Manager
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here